Experts names the blue chip ASX 200 shares to buy

A group of people in suits watch as a man puts his hand up to take the opportunity.

A group of people in suits watch as a man puts his hand up to take the opportunity.

Looking for some blue chip additions to your portfolio? Listed below are a couple of ASX 200 blue chip shares that have been given buy ratings by analysts

Here’s why its analysts rate them highly right now:

ResMed Inc. (ASX: RMD)

The first blue chip ASX 200 share that has been named as a buy is ResMed.

It is a medical device company with a focus on sleep treatment and respiratory products. These products treat disorders such as sleep apnoea and chronic obstructive pulmonary disease (COPD).

These certainly are great markets to be in.  For example, in respect to the former, the company estimates that upwards of 1 in 5 people are believed to suffer from sleep apnoea.

And with the vast majority currently undiagnosed, this provides a significant long term growth runway. Particularly given its industry-leading products, high level of investment in research and development each year, and wide distribution network.

Goldman Sachs is bullish on ResMed. It currently has a buy rating and $36.80 price target on its shares. This compares to the latest ResMed share price of $32.04.

Treasury Wine Estates Ltd (ASX: TWE)

Another blue chip ASX 200 share that is highly rated is Treasury Wine. It the global wine giant behind a range of popular brands including Penfolds.

Treasury Wine certainly has been through a lot in recent years but has come out of it looking arguably stronger.

In fact, the team at Morgans believe “the foundations are now in place for TWE to deliver strong earnings growth” in the coming years.

In light of this, Morgans has named Treasury Wine as a “key pick” and put an add rating and $13.93 price target on its shares. This compares to the current Treasury Wine share price of $12.55.

The post Experts names the blue chip ASX 200 shares to buy appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now

See The 5 Stocks
*Returns as of September 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed Inc. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Treasury Wine Estates Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/09rqXtL

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s